Finance

PTC Therapeutics' SWOT analysis: biotech stock faces pivotal year amid pipeline progress

https://www.investing.com/news/swot-analysis/ptc-therapeutics-swot-analysis-biotech-stock-faces-pivotal-year-amid-pipeline-progress-93CH-4063712 Investing.com

Revolution Medicines' SWOT analysis: stock shows promise amid clinical progress

https://www.investing.com/news/swot-analysis/revolution-medicines-swot-analysis-stock-shows-promise-amid-clinical-progress-93CH-4063713 Investing.com

Fate Therapeutics' SWOT analysis: stock outlook amid clinical progress

https://www.investing.com/news/swot-analysis/fate-therapeutics-swot-analysis-stock-outlook-amid-clinical-progress-93CH-4063709 Investing.com

AMTD Achieves Another Victory and Further Action Against IP Infringements

https://www.investing.com/news/press-releases/amtd-achieves-another-victory-and-further-action-against-ip-infringements-93CH-4063708 Investing.com

Earnings call transcript: hGears Q1 2025 sees revenue drop, stock slides

https://www.investing.com/news/transcripts/earnings-call-transcript-hgears-q1-2025-sees-revenue-drop-stock-slides-93CH-4063710 Investing.com

LegalZoom's SWOT analysis: stock faces growth challenges amid subscription shift

https://www.investing.com/news/swot-analysis/legalzooms-swot-analysis-stock-faces-growth-challenges-amid-subscription-shift-93CH-4063711 Investing.com

Euro could become the dollar's alternative, Lagarde says

https://www.investing.com/news/economy-news/euro-could-become-the-dollars-alternative-lagarde-says-4063706 Reuters

Half the world population could be diabetic or insulin resistant by 2050

with diabetes by 2050 and about three times that number will have pre-diabetes. over 5 billion people, or half of the...

Teradyne's SWOT analysis: semiconductor tester stock poised for AI-driven growth

https://www.investing.com/news/swot-analysis/teradynes-swot-analysis-semiconductor-tester-stock-poised-for-aidriven-growth-93CH-4063707 Investing.com

Latest articles

spot_imgspot_img